May 1, 2021
2 mins read

Serum Institute to start vaccine production in London

In an interview with The Times, CEO of Serum Institute of India Adar Poonawalla said that everything falls on his shoulders when it comes to delivering the Covid vaccine to millions in India., reports Asian Lite News

Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on Saturday that the company is also planning to start vaccine production in the UK, the media reported.

In an interview with The Times, Poonawalla said that everything falls on his shoulders when it comes to delivering the Covid vaccine to millions in India.

“I’m staying here (London) for an extended time because I don’t want to go back to that situation. Everything falls on my shoulders, but I can’t do it alone…I don’t want to be in a situation where you are just trying to do your job, and just because you can’t supply the needs of X, Y or Z, you really don’t want to guess what they are going to do,” Poonawalla told The Times.

Serum

Referring to the phone calls from some of the most powerful people in India to get them vaccines first, he added: “The level of expectation and aggression is really unprecedented. It’s overwhelming. Everyone feels they should get the vaccine. They can’t understand why anyone else should get it before them.”

India is facing an immense crunch of vaccines amid the lethal second Covid wave, and as the country started vaccination for people in the 18-44 age group in its third drive on Saturday, several states are unable to start the immunisation drive because of the demand-supply gap.

Also Read – Serum Institute says Covishield is most affordable jab

The CEO of the Pune-based pharmaceutical company said that the company will make an official announcement to produce vaccines in London in the coming days.

“There’s going to be an announcement in the next few days,” he said.

Recently, SII had borrowed money from banks instead of waiting for the government’s aid to arrive to scale up the production of its Covishield vaccine.

The company assumed that the funding from the government will reach them very soon, probably by this week.

Covishield has been developed by the Oxford University and AstraZeneca and manufactured by the SII.

The government recently announced that it has given in-principle approval for credit to vaccine manufacturers, SII and Hyderabad-based Bharat Biotech, to boost India’s vaccine production in the wake of the huge surge in Covid-19 caseload.

The Union Finance Ministry has approved to sanction Rs 3,000 crore credit for SII and Rs 1,500 crore for Bharat Biotech.

Poonawalla had earlier suggested that the company would require around Rs 3,000 crore to increase production of Covid-19 vaccines.

Previous Story

NWAMI’s Big Debate captures the audience

Next Story

ELECTION UPDATES 2021: NDA leads in Assam

Latest from -Top News

TIES WITH CHINA: Is Bangladesh Going Lanka Way?

Plans for nine Special Economic Zones, including Chinese-developed sites in Chattogram and Chandpur, promise jobs but risk creating enclaves where Beijing’s economic priorities overshadow Bangladesh’s….reports Asian Lite News On a humid March

Khaleda Zia’s Son Return Looms as Yunus Faces Heat

The core question remains whether Rahman can provide leadership in politically turbulent times in Bangladesh….reports Asian Lite News Speculation is mounting in Bangladesh over the possible return of Tarique Rahman, son of

India Eyes Top 5 Spot in Global Entertainment

With focused investments, policy support, and infrastructural upgrades, India is on track to position itself as one of the top five live entertainment destinations globally by 2030…reports Asian Lite News Fueled by
Go toTop

Don't Miss

INDIA ON ALERT

National Investigation Agency set to visit crime spot, raising the

EC Aims to Boost Urban Polling in Andhra

The urban areas, including Visakhapatnam, Nellore, Kurnool town, Rajamahendravaram, and